News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,215 Results
Type
Article (40877)
Company Profile (267)
Press Release (680061)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (204660)
Career Advice (2022)
Deals (35533)
Drug Delivery (110)
Drug Development (81372)
Employer Resources (173)
FDA (16403)
Job Trends (14941)
News (346359)
Policy (32723)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2565)
Accelerated approval (31)
Adcomms (24)
Allergies (137)
Alliances (49578)
ALS (168)
Alzheimer's disease (1660)
Antibody-drug conjugate (ADC) (305)
Approvals (16668)
Artificial intelligence (503)
Autoimmune disease (148)
Automation (37)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (632)
Cancer (4754)
Cardiovascular disease (395)
Career advice (1707)
Career pathing (35)
CAR-T (277)
CDC (44)
Celiac Disease (2)
Cell therapy (731)
Cervical cancer (36)
Clinical research (69496)
Collaboration (1670)
Company closure (4)
Compensation (1147)
Complete response letters (52)
COVID-19 (2707)
CRISPR (87)
C-suite (816)
Cystic fibrosis (143)
Data (6160)
Decentralized trials (2)
Denatured (25)
Depression (130)
Diabetes (497)
Diagnostics (6670)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (242)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (228)
Earnings (90041)
Editorial (55)
Employer branding (21)
Employer resources (151)
Events (117201)
Executive appointments (959)
FDA (19486)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1445)
Gene editing (191)
Generative AI (42)
Gene therapy (586)
GLP-1 (962)
Government (4652)
Grass and pollen (6)
Guidances (383)
Healthcare (18869)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (244)
Immuno-oncology (54)
Indications (104)
Infectious disease (2966)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (242)
Interviews (315)
IPO (16638)
IRA (49)
Job creations (3641)
Job search strategy (1427)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (545)
Leadership (30)
Legal (7948)
Liver cancer (91)
Longevity (14)
Lung cancer (641)
Lymphoma (372)
Machine learning (42)
Management (59)
Manufacturing (777)
MASH (161)
Medical device (13756)
Medtech (13808)
Mergers & acquisitions (19954)
Metabolic disorders (1254)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (309)
Neuropsychiatric disorders (86)
Neuroscience (2873)
Neurotech (1)
NextGen: Class of 2026 (6520)
Non-profit (4511)
Now hiring (65)
Obesity (588)
Opinion (257)
Ovarian cancer (164)
Pain (197)
Pancreatic cancer (222)
Parkinson's disease (279)
Partnered (33)
Patents (488)
Patient recruitment (473)
Peanut (55)
People (58816)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21666)
Phase 2 (30587)
Phase 3 (22791)
Pipeline (5114)
Policy (278)
Postmarket research (2564)
Preclinical (9190)
Press Release (64)
Prostate cancer (234)
Psychedelics (47)
Radiopharmaceuticals (277)
Rare diseases (818)
Real estate (5954)
Recruiting (69)
Regulatory (24425)
Reports (51)
Research institute (2383)
Resumes & cover letters (351)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (146)
Series A (237)
Series B (185)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3613)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (53)
Vaccines (984)
Venture capital (86)
Weight loss (377)
Women's health (87)
Worklife (18)
Date
Today (79)
Last 7 days (564)
Last 30 days (2031)
Last 365 days (29814)
2026 (2903)
2025 (30172)
2024 (35217)
2023 (40078)
2022 (51179)
2021 (55712)
2020 (54085)
2019 (46541)
2018 (35021)
2017 (32109)
2016 (31483)
2015 (37554)
2014 (31319)
2013 (26345)
2012 (28571)
2011 (29264)
2010 (27332)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (305)
Arkansas (13)
Asia (39196)
Australia (6406)
California (11166)
Canada (3255)
China (1087)
Colorado (472)
Connecticut (470)
Delaware (332)
Europe (84438)
Florida (1662)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (852)
India (62)
Indiana (515)
Iowa (22)
Japan (420)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1370)
Massachusetts (8001)
Michigan (319)
Minnesota (622)
Mississippi (5)
Missouri (127)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2969)
New Mexico (28)
New York (2944)
North Carolina (1436)
North Dakota (8)
Northern California (5442)
Ohio (329)
Oklahoma (21)
Oregon (41)
Pennsylvania (2257)
Puerto Rico (22)
Rhode Island (47)
South America (1107)
South Carolina (65)
South Dakota (1)
Southern California (4346)
Tennessee (172)
Texas (1724)
United States (39590)
Utah (333)
Vermont (1)
Virginia (256)
Washington D.C. (81)
Washington State (913)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
721,215 Results for "mmi inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MMI Wins FDA Clearance and Completes First U.S. Clinical Use of Robotic Microsurgical Dissection Instruments with Symani
December 10, 2025
·
4 min read
Press Releases
MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential
December 2, 2025
·
4 min read
Press Releases
MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
November 6, 2025
·
4 min read
Press Releases
MMI Enrolls First Patient in Landmark U.S. Clinical Study Advancing Robotic Microsurgery
October 16, 2025
·
3 min read
MMI Completes First Symani® Clinical Cases in the U.S. Following FDA Commercial Authorization
MMI (Medical Microinstruments, Inc.) today announced the completion of its first clinical cases in the United States using the Symani® Surgical System.
May 1, 2024
·
3 min read
MMI Receives FDA Authorization to Commercialize Symani® Surgical System in the U.S.
MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced that its Symani® Surgical System is now commercially available in the United States.
April 8, 2024
·
4 min read
BioMidwest
MMI Raises $110 Million in Series C Financing
MMI, a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, announced that it has raised $110 million in Series C financing.
February 21, 2024
·
3 min read
MMI to Present at the 42nd Annual J.P. Morgan Healthcare Conference
MMI (Medical Microinstruments, Inc.) today announced the company has been invited to participate in the 42nd Annual J.P. Morgan Healthcare Conference taking place in San Francisco.
January 4, 2024
·
2 min read
BioMidwest
MMI’s Symani® Robotic Surgical System Surpasses 500 Clinical Procedures
MMI, a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, announced the successful completion of over 500 in-human surgeries with the Symani® Surgical System in the European Union.
September 25, 2023
·
4 min read
MMI to Present at the 41st Annual J.P. Morgan Healthcare Conference
MMI ( Medical Microinstruments, Inc. ), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced that it will participate in the 41st Annual J.P. Morgan Healthcare Conference taking place in San Francisco, California on January 9-12, 2023.
January 4, 2023
·
1 min read
1 of 72,122
Next
